Cargando…

Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence

The live-attenuated oral poliovirus vaccine (OPV or Sabin vaccine) replicates in gut-associated tissues, eliciting mucosa and systemic immunity. OPV protects from disease and limits poliovirus spread. Accordingly, vaccination with OPV is the primary strategy used to end the circulation of all poliov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeh, Ming Te, Bujaki, Erika, Dolan, Patrick T., Smith, Matthew, Wahid, Rahnuma, Konz, John, Weiner, Amy J., Bandyopadhyay, Ananda S., Van Damme, Pierre, De Coster, Ilse, Revets, Hilde, Macadam, Andrew, Andino, Raul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566161/ https://www.ncbi.nlm.nih.gov/pubmed/32330425 http://dx.doi.org/10.1016/j.chom.2020.04.003

Ejemplares similares

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study
por: Van Damme, Pierre, et al.
Publicado: (2019)

Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses
por: Wahid, Rahnuma, et al.
Publicado: (2021)

Improvement of the qmosRT-PCR Assay and Its Application for the Detection and Quantitation of the Three Serotypes of the Novel Oral Polio Vaccine in Stool Samples
por: Manukyan, Hasmik, et al.
Publicado: (2023)

Quantitative RT-PCR Assays for Quantification of Undesirable Mutants in the Novel Type 2 Oral Poliovirus Vaccine
por: Manukyan, Hasmik, et al.
Publicado: (2022)

Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3
por: Yeh, Ming Te, et al.
Publicado: (2023)

Evaluation and validation of next-generation sequencing to support lot release for a novel type 2 oral poliovirus vaccine
por: Konz, John O., et al.
Publicado: (2021)

Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials
por: Wahid, Rahnuma, et al.
Publicado: (2022)

Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children
por: Wahid, Rahnuma, et al.
Publicado: (2022)

Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization
por: Konopka-Anstadt, Jennifer L., et al.
Publicado: (2020)

Assessing and Mitigating Local Vulnerabilities to Completeness of Global Polio Eradication
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2021)

Safeguarding vaccine production and supply strategies for polio eradication endgame
por: Bandyopadhyay, Ananda S., et al.
Publicado: (2021)

Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2018)

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials
por: De Coster, Ilse, et al.
Publicado: (2021)

Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience()
por: Macklin, Grace R., et al.
Publicado: (2023)

Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame
por: Gaensbauer, James T, et al.
Publicado: (2018)

Plant-made polio type 3 stabilized VLPs—a candidate synthetic polio vaccine
por: Marsian, Johanna, et al.
Publicado: (2017)

Development of a Quantitative One-Step RT-PCR Method for the Detection of Sabin 2 Virus Contamination in a Novel Oral Poliovirus Vaccine Type 2
por: Manukyan, Hasmik, et al.
Publicado: (2021)

High Diversity of Human Non-Polio Enterovirus Serotypes Identified in Contaminated Water in Nigeria
por: Majumdar, Manasi, et al.
Publicado: (2021)

Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in Belgium
por: Brickley, Elizabeth B, et al.
Publicado: (2020)

New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication
por: Knowlson, Sarah, et al.
Publicado: (2015)

StralSV: assessment of sequence variability within similar 3D structures and application to polio RNA-dependent RNA polymerase
por: Zemla, Adam T, et al.
Publicado: (2011)

Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines
por: Bahar, Mohammad W., et al.
Publicado: (2021)

Time Taken to Detect and Respond to Polio Outbreaks in Africa and the Potential Impact of Direct Molecular Detection and Nanopore Sequencing
por: Shaw, Alexander G, et al.
Publicado: (2021)

Acute Polio-Encephalitis and Polio-Myelitis
Publicado: (1905)

Polio health economics: assessing the benefits and costs of polio, non-polio, and integrated activities of the Global Polio Eradication Initiative
por: Thompson, Kimberly M., et al.
Publicado: (2022)

Polio
por: Gould, Tony
Publicado: (1999)

Polio
por: Viswanathan, R.
Publicado: (1949)

Polio
por: Pucchio, Aoife M.R., et al.
Publicado: (2022)

Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden
por: Brickley, Elizabeth B, et al.
Publicado: (2019)

The Challenge of Polio
por: Horstmann, Dorothy M.
Publicado: (1947)

Polio-Consciousness
Publicado: (1949)

The resurgence of polio: The effect of the Covid-19 pandemic on polio eradication
por: Niaz, F., et al.
Publicado: (2023)

Mapping Attenuation Determinants in Enterovirus-D68
por: Yeh, Ming Te, et al.
Publicado: (2020)

Examining the interplay between face mask usage, asymptomatic transmission, and social distancing on the spread of COVID-19
por: Catching, Adam, et al.
Publicado: (2021)

A tradeoff between enterovirus A71 particle stability and cell entry
por: Catching, Adam, et al.
Publicado: (2023)

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15–18 months
por: Sáez-Llorens, Xavier, et al.
Publicado: (2020)

Polio Legacy in Action: Using the Polio Eradication Infrastructure for Measles Elimination in Nigeria—The National Stop Transmission of Polio Program
por: Michael, Charles A., et al.
Publicado: (2017)

Impact of polio vaccines (oral polio vaccine - OPV or inactivated polio vaccine - IPV) on rotavirus vaccine-associated intussusception
por: Martini Rodrigues, Camila Cristina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o3vjrsv4oivqptou3hvb0s5lm8